Deregulation of the ubiquitin-protein ligase E6AP contributes to the development of the Angelman syndrome and to cervical carcinogenesis suggesting that the activity of E6AP needs to be under tight control. However, how E6AP activity is regulated at the post-translational level under non-pathologic conditions is poorly understood. In this study, we report that the giant protein HERC2, which is like E6AP a member of the HECT family of ubiquitin-protein ligases, binds to E6AP. The interaction is mediated by the RCC1-like domain 2 of HERC2 and a region spanning amino acid residues 150 -200 of E6AP. Furthermore, we provide evidence that HERC2 stimulates the ubiquitinprotein ligase activity of E6AP in vitro and within cells and that this stimulatory effect does not depend on the ubiquitin-protein ligase activity of HERC2. Thus, the data obtained indicate that HERC2 acts as a regulator of E6AP.Covalent modification of proteins by ubiquitin ("ubiquitination") plays a prominent role in the control of many fundamental cellular processes, including cell cycle control, DNA repair, and apoptosis. Substrate recognition and, thus, specificity of the ubiquitin-conjugation system are mainly mediated by ubiquitin-protein ligases E3 5 (1-3). Based on structural and mechanistic considerations, E3s can be grouped into two families, E3s containing a RING or RING-like domain and E3s with a HECT domain. Both domains serve as interaction sites for E2 ubiquitin-conjugating enzymes. However, whereas in the case of RING E3s attachment of ubiquitin to substrates is catalyzed by the interacting E2, HECT E3s first accept ubiquitin from their cognate E2s by formation of a thioester complex with ubiquitin and then transfer ubiquitin to substrates (1-3).Because many cellular processes are controlled by ubiquitination, it is not surprising that deregulation of components of the ubiquitin-conjugation system contributes to the development of human diseases (1-4). E6AP, the founding member of the HECT family of E3s, represents one of the most prominent examples for this notion. Inactivation of the E3 activity of E6AP by mutation or loss of expression results in the development of the Angelman syndrome, a neurodevelopmental disorder, whereas unscheduled activation of E6AP by interaction with the E6 oncoprotein of certain human papillomaviruses, including HPV16, contributes to cervical carcinogenesis (5-9). Thus, thorough characterization of E6AP and its substrates and regulators should provide important insights into the mechanisms underlying the pathogenesis of the aforementioned diseases.E6AP is encoded by the UBE3A gene located on chromosome 15q11-13 and exists in three isoforms generated by differential splicing (7, 10, 11). The isoforms differ at their N termini, but it is currently unknown if the isoforms have different properties (e.g. protein-binding properties). Several substrates of E6AP have been reported, including HHR23A and HHR23B, Blk, AIB1, PML, alpha-Synuclein, Arc, and Ring1B (12-18). However, with the exception of Arc and potentia...